Kosnopfel C, Sinnberg T, Sauer B, et al. MAPK inhibitor resistant melanoma cells can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. SMR 2017, abstract P01-9.
NIVO3+IPI1 versus NIVO1+IPI3 bij gevorderd melanoom: CheckMate 511
apr 2019 | Dermato-oncologie, Immuuntherapie